Reports
Reports
Sale
The global forskolin market size is projected to grow at a CAGR of 8% between 2024 and 2032.
Forskolin, also known as coleonol, and pashanabhedi, among other names, is a natural supplement derived from the root of a Coleus forskohlii plant (Indian coleus), a member of the mint family. The plant is mostly found in India, Thailand, and the countries of Southeast Asia. The extracts of forskolin are of high medicinal value. It has long been used in folk medicine and Ayurveda to treat various ailments and breathing disorders like asthma. Nowadays, it is marketed as a popular weight loss supplement.
The global forskolin market growth is driven by the rising health awareness among consumers, coupled with the growing inclination towards natural and plant-based products. The growing incidences of respiratory problems, obesity, and cardiovascular disorders across different parts of the world are further driving the demand for the product owing to its numerous health benefits and therapeutic efficacy. The growing focus on grooming and appearance is resulting in an increased demand for weight loss or dietary supplements. Consumers are looking for products with natural ingredients as they do not possess the risk of side effects, which is significantly boosting the sales of the product. Further, the improving standards of living and the rising consumer disposable incomes, particularly in emerging nations, are also aiding the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Weight management and sports nutrition; research and clinical studies; innovations in product formulation and delivery; and online sales and direct-to-consumer marketing are the major trends impacting the forskolin market expansion
Date | Event |
May 2023 | The Sami-Sabinsa Group, a manufacturer of forskolin, partnered with O2 Renewable Energy to leverage latter’s solar energy sources for its manufacturing plants in Karnataka, India. |
Sep 2023 | Sabinsa, a globally recognised provider of nutraceutical and cosmeceutical ingredients, is expanding its international footprint by opening a new office in Montpon-Ménéstérol, located in the southwest of France. |
Trends | Impact |
Weight management and sports nutrition | A significant trend of forskolin market is its association with weight loss and fat burning, making it a common ingredient in weight management and sports nutrition products. |
Research and clinical studies | Forskolin has been the subject of various clinical studies aimed at understanding its efficacy in weight loss and treating heart conditions, asthma, and other disorders. |
Innovations in product formulation and delivery | There is a trend towards the development of novel formulations and delivery methods, such as enhanced absorption forskolin, combination products, and convenient dosing forms. |
Online sales and direct-to-consumer marketing | With the rise of e-commerce and digital marketing, nutraceutical brands can reach a broader audience, boosting forskolin’s role as an essential ingredient in dietary supplements. |
Growing technological advancements in product development and extraction processes | These advancements enhance the purity and efficacy of forskolin extracts and contribute to the sustainability and efficiency of production methods. |
There is a significant shift towards natural and holistic approaches to health and wellness, including weight loss. Consumers are increasingly wary of synthetic drugs due to their potential side effects, and are turning towards natural supplements like forskolin, which is derived from the Coleus forskohlii plant, as safer alternatives. With rising awareness about the health risks associated with obesity and sedentary lifestyles, individuals are more focused on fitness and weight management. Forskolin, believed to aid in fat burning and weight loss, is used as an ingredient in various supplements that naturally attract consumers looking to enhance their fitness regimes, thus supporting the forskolin market development.
The leading market players are focusing on improving their capacity and are also upgrading their production methods to meet sustainability goals. For instance, the agreement announced between Sami-Sabinsa Group and O2 Renewable Energy in May 2023 marks a significant step towards sustainability and environmental responsibility for the former, a renowned player in the nutraceutical and cosmeceutical sector. By committing to use solar power for its manufacturing processes in Karnataka, India, the group is making a clear statement about its commitment to reducing carbon footprints and promoting green energy solutions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
“Forskolin Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:
Market Breakup | Categories |
Concentration | Low Concentration (10%), Medium Concentration (20%-40%), High Concentration (95%) |
Application | Allergy Treatment, Weight Management, Respiratory Problems, Cardiovascular Disorders, Glaucoma, Hypothyroidism, Psoriasis, Others |
End Use | Nutraceuticals, Pharmaceuticals, Dietary Supplements, Others |
Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Weight management application accounts for a major forskolin market share as the product is widely used in supplements due to its ability to stimulate the release of excess fat in cells
Weight management applications of forskolin occupy a substantial market share as forskolin is believed to stimulate the release of stored fat from fat cells, a process similar to how the body uses fat for energy when fasting or exercising. This mechanism is thought to promote weight loss by increasing fat breakdown. Forskolin is also known to activate adenylate cyclase, an enzyme that increases levels of cyclic adenosine monophosphate (cAMP) in cells. Elevated cAMP levels are associated with an increased rate of fat loss and can improve the effectiveness of other fat-burning compounds. cAMP plays a critical role in the regulation of metabolism, and its enhancement could support a more efficient metabolic rate.
Moreover, forskolin has garnered interest in the field of cardiovascular medicine due to its unique mechanism of action, particularly its ability to activate the enzyme adenylate cyclase, which increases levels of cyclic adenosine monophosphate (cAMP) in cells. cAMP is a crucial second messenger important for the cellular responses to hormones and other extracellular signals. This increase in cAMP has several effects on the heart and blood vessels, making forskolin of potential interest in treating cardiovascular disorders.
Dietary supplements maintain their dominance in the market as forskolin finds growing usage in supplements supporting weight loss and boosting metabolism
The forskolin market demand is driven by the growing usage of forskolin in dietary supplements. Forskolin is widely recognised for its weight management benefits, which aligns well with the dietary supplement sector’s focus. The demand in this sector is driven by consumers seeking natural alternatives for weight loss and body composition improvement. Dietary supplements that contain forskolin are marketed for their ability to promote fat breakdown, support metabolism, and sometimes even for their potential benefits in improving cardiovascular health and other conditions.
Nutraceuticals are also anticipated to gain significant growth in the forskolin market in the coming years. These products are derived from food sources with extra health benefits in addition to the basic nutritional value found in foods. Forskolin fits into this category because of its health benefits that go beyond basic nutrition, such as potential applications in managing cardiovascular disorders, supporting respiratory health, and possibly aiding in conditions like glaucoma and hypothyroidism.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market players are increasing their collaboration and research and development activities to gain a competitive edge in the market
Company | Operations | Headquarters | Products |
Sabinsa Corporation | Development and manufacturing of herbal extracts, minerals, and dietary supplements | New Jersey, United States | Herbal extracts, cosmeceuticals, and dietary supplements |
Nutra Green Biotechnology Co., Ltd | Focuses on the research, development, and manufacturing of natural plant extracts and nutritional supplements | Shanghai, China | Tea extracts, herbal extracts, and speciality ingredients |
Varion Lifesciences Pvt. Ltd | Manufacture of speciality nutraceutical ingredients, novel plant extracts, active pharmaceutical ingredients (APIs) | Gujarat, India | Active pharmaceutical ingredients (APIs) and formulations. |
Alchem International Pvt Ltd | Manufacturer of phytochemicals and herbal extracts | New Delhi, India | Natural active pharmaceutical ingredients (APIs), nutraceutical ingredients, and cosmetic ingredients |
Other major players in the market include Cymbio Pharma Pvt Ltd, among others. The market players are engaging in a variety of activities to capitalise on the growing demand for natural health products and supplements.
The Asia Pacific is expected to provide significant growth opportunities over the forecast period due to the easy availability of forskolin in the region. Further, the rapidly developing economies within the region, particularly India and China, represent high growth potential for the market. The improving standards of living, the presence of a large population, and the increased reliance on herbal products favour the growth of the forskolin market in these nations.
Other regions like North America and Europe are witnessing an increased demand for natural products owing to the rising health consciousness among consumers. The increasing obesity levels and the growing prevalence of weight-related problems are driving the demand for weight loss supplements in the region, thus leaving immense scope for market expansion in the coming years.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Concentration |
|
Breakup by Application |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Forskolin Market Analysis
8.1 Key Industry Highlights
8.2 Global Forskolin Historical Market (2018-2023)
8.3 Global Forskolin Market Forecast (2024-2032)
8.4 Global Forskolin Market by Concentration
8.4.1 Low Concentration (10%)
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Medium Concentration (20%-40%)
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 High Concentration (95%)
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Global Forskolin Market by Application
8.5.1 Allergy Treatment
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Weight Management
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Respiratory Problems
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Cardiovascular Disorders
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Glaucoma
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Hypothyroidism
8.5.6.1 Historical Trend (2018-2023)
8.5.6.2 Forecast Trend (2024-2032)
8.5.7 Psoriasis
8.5.7.1 Historical Trend (2018-2023)
8.5.7.2 Forecast Trend (2024-2032)
8.5.8 Others
8.6 Global Forskolin Market by End Use
8.6.1 Nutraceuticals
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmaceuticals
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Dietary Supplements
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Forskolin Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Forskolin Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Forskolin Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Forskolin Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Forskolin Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Forskolin Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Sabinsa Corporation
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Nutra Green Biotechnology Co., Ltd.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Varion Lifesciences Pvt. Ltd.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Alchem International Pvt Ltd
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Cymbio Pharma Pvt Ltd
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Forskolin Market: Key Industry Highlights, 2018 and 2032
2. Global Forskolin Historical Market: Breakup by Concentration (USD Million), 2018-2023
3. Global Forskolin Market Forecast: Breakup by Concentration (USD Million), 2024-2032
4. Global Forskolin Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Forskolin Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Forskolin Historical Market: Breakup by End Use (USD Million), 2018-2023
7. Global Forskolin Market Forecast: Breakup by End Use (USD Million), 2024-2032
8. Global Forskolin Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Forskolin Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Forskolin Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Forskolin Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Forskolin Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Forskolin Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Forskolin Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Forskolin Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Forskolin Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Forskolin Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Forskolin Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Forskolin Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Forskolin Market Structure
The global forskolin market is projected to grow at a CAGR of 8% between 2024 and 2032.
The major drivers of the industry, such as rising disposable incomes, increasing population, enhancing standards of living, rising demand for herbal supplements, increasing inclination towards natural and plant-based products, and rising health consciousness, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising demand for organic products and growing technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading concentrations of forskolin in the industry are low concentration (10%), medium concentration (20%-40%), and high concentration (95%).
The major application segments in the market are allergy treatment, weight management, respiratory problems, cardiovascular disorders, glaucoma, hypothyroidism, and psoriasis, among others.
The significant end-use sectors in the industry are nutraceuticals, pharmaceuticals, and dietary supplements, among others.
The major players in the market are Sabinsa Corporation, Nutra Green Biotechnology Co., Ltd., Varion Lifesciences Pvt. Ltd., Alchem International Pvt Ltd, and Cymbio Pharma Pvt Ltd, among others.
The global forskolin market is being driven by the rising demand for herbal supplements. Aided by the growing product launches, the market is expected to witness a healthy growth in the forecast period of 2024-2032, growing at a CAGR of 8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By concentration, the market can be segmented into low concentration (10%), medium concentration (20%-40%), and high concentration (95%). On the basis of application, the industry can be divided into allergy treatment, weight management, respiratory problems, cardiovascular disorders, glaucoma, hypothyroidism, and psoriasis, among others. Based on end use, the market can be segmented into nutraceuticals, pharmaceuticals, and dietary supplements, among others. The major regional markets for forskolin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sabinsa Corporation, Nutra Green Biotechnology Co., Ltd., Varion Lifesciences Pvt. Ltd., Alchem International Pvt Ltd, and Cymbio Pharma Pvt Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.